Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

Jaipur: A new study from JK Lon Hospital, state's largest govt paediatric facility, has revealed significant deficiencies in ...

BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

The global vitamin K2 market is rapidly growing due to its role in preventing cardiovascular diseases and supporting bone ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...

Jaipur: Health department Wednesday took cognisance of a report published in TOI about deaths of infants caused by ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

By Gift BritonFor the first time, infants younger than 28 days (neonates) can safely receive Dolutegravir (DTG), one of the most effective and widely used HIV drugs worldwide.Since the World Health ...